Business Description
Raphael Pharmaceutical Inc
NAICS : 325411
SIC : 2833
ISIN : US27785B2088
Description
Raphael Pharmaceutical Inc is a pharmaceutical drug research and development company focused on the discovery and clinical development of life-improving drug therapies based on cannabinoids, including cannabidiol, or CBD oil.
Financial Strength
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | No Debt | |||||
Equity-to-Asset | -0.29 | |||||
Piotroski F-Score | 3/9 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | -18.2 | |||||
3-Year EPS without NRI Growth Rate | -14.5 | |||||
3-Year FCF Growth Rate | -12.9 |
Momentum Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 56 | |||||
9-Day RSI | 54.59 | |||||
14-Day RSI | 55.45 | |||||
6-1 Month Momentum % | 64 | |||||
12-1 Month Momentum % | 13.1 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 0.77 | |||||
Quick Ratio | 0.77 | |||||
Cash Ratio | 0.63 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -6.1 | |||||
Shareholder Yield % | -3.82 |
Profitability Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
ROE % | -77157.89 | |||||
ROA % | -1074.78 | |||||
ROIC % | -33895.35 | |||||
ROC (Joel Greenblatt) % | -182187.5 | |||||
ROCE % | -76710.53 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
EV-to-EBIT | -10.46 | |||||
EV-to-EBITDA | -10.46 | |||||
EV-to-FCF | -31.22 | |||||
Earnings Yield (Greenblatt) % | -9.56 | |||||
FCF Yield % | -3.17 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:RAPH
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Raphael Pharmaceutical Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil $) | |||
EPS (TTM) ($) | -0.18 | ||
Beta | 0 | ||
Volatility % | 78.83 | ||
14-Day RSI | 55.45 | ||
14-Day ATR ($) | 0.092381 | ||
20-Day SMA ($) | 1.5985 | ||
12-1 Month Momentum % | 13.1 | ||
52-Week Range ($) | 0.6 - 1.67 | ||
Shares Outstanding (Mil) | 18.66 |
Piotroski F-Score Details
Year:
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 3 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Raphael Pharmaceutical Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Raphael Pharmaceutical Inc Stock Events
Event | Date | Price($) | ||
---|---|---|---|---|
No Event Data |
Raphael Pharmaceutical Inc Frequently Asked Questions
What is Raphael Pharmaceutical Inc(RAPH)'s stock price today?
The current price of RAPH is $1.65. The 52 week high of RAPH is $1.67 and 52 week low is $0.60.
When is next earnings date of Raphael Pharmaceutical Inc(RAPH)?
The next earnings date of Raphael Pharmaceutical Inc(RAPH) is .
Does Raphael Pharmaceutical Inc(RAPH) pay dividends? If so, how much?
Raphael Pharmaceutical Inc(RAPH) does not pay dividend.
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |